SummARY In 30 patients with systemic lupus erythematosus the number of circulating basophils was counted in different stages of activity. An inverse correlation was found between the absolute basophil count and anti-DNA antibodies and presumptive circulating immune complexes (as judged by polyethylene glycol precipitation of serum). A positive correlation was found between the absolute basophil count and C3 or C4 levels. IgE on the basophil surface was determined by radioimmunoassay in 7 patients. All of them showed a significantly high surface IgE number. When the count of circulating basophils was roughly normal, 5 out of the 6 patients showed a positive basophil degranulation test with native DNA. These results suggest the existence of an anti-DNA specific IgE in lupus patients. Depression of the circulating basophil count may be a useful index of lupus activity.
In the acute serum sickness of rabbits the deposition of immune complexes in the blood-vessel walls involves an increase in vascular permeability induced by the release ofvasoactive amines from the platelets.'
In these animals the occurrence of the glomerular lesions is particularly associated with antigendependent histamine release from leucocytes2; and, on addition of the antigen, basophils sensitised with IgE degranulate and release also a plateletactivating factor (PAF) which aggregates platelets and releases their histamine. 3 We have recently shown that a diminution of circulating basophils precedes the onset of proteinuria in acute experimental serum sickness; and those rabbits whose basophil count remained normal showed no proteinuria, although they had circulating immune complexes bigger than 19 S in size. 4 The role of immediate hypersensitivity in immune complex diseases in man has received little attention.5-8 Accordingly, the purpose of this work was to study the implication of the IgE-basophil system in systemic lupus erythematosus, a prototype of immune complex disease in man.
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Materials and methods
We studied 30 patients with systemic lupus erythematosus, who fulfilled diagnostic clinical criteria of the American Rheumatism Association (ARA) and certain immunological criteria (antinuclear antibodies, anti-DNA antibodies and low serum complement). All patients had renal involvement, shown by renal biopsy, confirmed by light microscopy, immunofluorescence, and in some cases electron microscopy.
STAINING AND COUNTING OF BASOPHILS
The technique has been described previously in rabbits,9 but it has also been found useful for human basophil counting.'0 Briefly, blood and dye were mixed in a 1/10 proportion and placed in both chambers of a Fuchs-Rosenthal cell. In order to study whether a depressed circulating basophil count represented another sign of lupus activity this parameter was compared with some immunological data generally considered to be 'markers' of activity. Correlations emerged between circulating basophil count and DNA antibodies (expressed as DNA-binding percentage) and serum C3 and C4 levels; these relationships are shown in Figs. 1, 2, and 3, respectively. No correlation was found with serum C3PA levels. The relationship between basophil counts and PEG precipitation in 28 patients is shown in Fig. 4 . In those patients having a positive precipitation with PEG the average basophil count was 9-42 ± 6-95 (SD)/mm3, while it was 19 40 ± 14.87/mm3 in those having it negative (P<0-001). A significant correlation was also found when we compared the average values E SD of the percentage of basophils in relation to the total leucocytes (0-20 ± 0-14 versus 0 44 + 0 31) in these 2 groups.
CIRCULATING BASOPHIL SENSITISATION WITH RESPECT TO NATIVE DNA Five out of 6 patients whose basophils were incubated with sonicated DNA showed degranulation greater than 30% (Fig. 5) Fig. 3 Correlation between the number of circulating basophils and serum C4. the number of IgE molecules was determined on the occasion of a degranulation test using sonicated DNA. All but patient 3 showed a significant degranulation, which suggests the existence of DNA specific IgE. There was no overall relationship between the number of basophil associated IgE molecules and the percentage of degranulation, possibly because the basophil cells might have been sensitised against other nuclear antigens. This could also explain the discordance observed in patient 4, though both tests were repeated after an interval of several months and at different stages of clinical activity.
Discussion
There are few available data on the role of the IgEbasophil system in immune complex disease in man. Normally the IgE molecules produced in an immune response bind preferentially to membrane receptors of basophils and mast cells, and their presence in serum can be detected only when there is an excess production of IgE.9 In that sense a very high degree of active or passive sensitisation could be achieved without detectable serum IgE-specific levels (in such diverse antigenic systems as peroxidase or bovine serum albumin).9 Therefore the presence of detectable IgE antibodies in serum is not a necessary index of basophil sensitisation.
Our results in experimental serum sickness have shown that the IgE basophil system plays a key role in the deposition of circulating immune complexes in the rabbit. In these experiments diminution of circulating basophils, most probably reflecting invivo degranulation, occurred 24-48 hours before the onset of proteinuria. The rabbits whose basophil count remained normal showed no proteinuria, though they had circulating immune complexes bigger than 19 S in size. The majority of animals with a reduced basophil count gave a positive in-vitro degranulation test with the antigen bovine serum albumin (BSA) during the period immediately following elimination of more than 99% of the circulating BSA. 4 We suggest that a similar phenomenon might be occurring in the present series of lupus patients.
Circulating basophil counts in lupus patients were significantly lower than controls. Since many of these patients were not on steroid therapy, which could slightly lower their basophil number,18 it was thought that these cells could be sensitised against a range of nuclear antigens, particularly DNA.
A positive basophil degranulation test with n-DNA was detected in the majority of the patients. The possibility cannot be ruled out that antibodies to other nuclear antigens might also sensitise basophils. In this context it has recently been shown8 that the basophils of patients with rheumatoid arthritis can liberate histamine in the presence of RNA as well as DNA.
The basophils of all lupus patients showed a much greater content of surface IgE than the controls. The lack of a complete correlation with the extent of basophil degranulation induced by DNA could be due in part to sensitisation against other nuclear antigens.
Anti-DNA antibodies in serum of patients with systemic lupus erythematosus have been considered highly specific for the disease and constitute an excellent diagnostic criterion.19 Many authors consider that a decrease in serum complement values together with an increase in these antibodies may indicate relapse of disease even before clinical signs and symptomatology. Our results show a correlation between the basophil number and the titre of anti-DNA antibodies and the complement factors C3 and C4. We thus felt that this simple determination could figure among the other immunological criteria in the assessment of disease activity.
In rabbits a good correlation has been shown between the antigen-specific basophil degranulation and the release of histamine and platelet activating factor (PAF).3 We suggest that lupus patients in activity might in this respect resemble rabbits immunised daily with low doses of antigen. On this basis we suggest further that when an animal or, in this case, a lupus patient is immunised against a specific antigen, IgE antibodies are produced which early sensitise the basophils and mast cells, loaded with potent mediators. Further contact with the antigen will provoke the liberation of these mediators, consequently increasing capillary permeability and the deposition of circulating immune complexes. We suggest that drugs active against basophil degranulation might represent a useful therapeutic adjunct in the management of systemic Jupus. Furthermore, depression of circulating basophils may prove to be a useful index of lupus activity. 
